The destruction of vascular smooth muscle cells (VSMC) in autoimmune arteritis is a poorly understood phenomenon. To approach this problem, VSMC cultures were established. The interaction of these cells (from normal or autoimmune mice) with lymphocytes was then evaluated. Specifically, splenocytes from MRUlpr or C3H mice were co-cultivated with MRUlpr or C3H VSMCs. Massive mononuclear inflammatory cell clusters enveloped MRUlpr VSMCs which culminated in the detachment of MRL/lpr VSMCs fromthe culture plate. In contrast, the interaction of splenocytes from normal or autoimmune micedid not destroy normal VSMCs. Further investigation indicated that MRUlpr VSMCs spontaneously expressed both Ia-k and Ia-d, as assessed by fluorescence microscopy and flow cytometry, and released interleukin-llike factors-characteristics of accessory cells to T-Iymphocyte function. Evaluation of VSMCs accessory function in antigen presentation suggests that these cells may present antigen under specific experimental conditions. As a result of these studies, a novel mechanism of autoimmune vasculitis is proposed. Our hypothesis is that defective biological function ofVSMCs from autoimmune mice stimulates a mononuclear inflammatory cell response which culminates in VSMC autodestruction.
INTRODUCTION
Our laboratory has been examining the interaction of vascular smooth muscle cells (V8MCs) with lymphocytes and macrophages in the induction of autoimmune vasculitis. Cell-mediated immunologic mechanisms in autoimmune disease are currently iriadequately defined. Specific inbred mice, such as the MRL/lpr mouse, have been developed to study the immunopathologic mechanisms governing the development of autoimmune lesions (2, 10, 13, 18, 22) . These mice, as a component oftheir autoimmune disease, express 2 morphologically distinct types of vasculitis: a) neutrophilic, immune complex-mediated, and b) mononuclear-cell vasculitis (1). Of these 2 types, the pathologic mecha-
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I Presented at the Toxicology Forum inAspen, Colorado, July [9] [10] [11] 1987 . 122 nisms underlying the development of neutrophilic vasculitis have been the best characterized (6, 7) . The cellular interactions governing the expression ofmononuclear-cell vasculitis are unknown (11, 15) . Currently, the best-studied mechanism producing vasculitis is the neutrophilic, immune complex-mediated mechanism described by Frank Dixon in 1963 ( Fig. 1) (4, 8, 21) . This mechanism may be summarized as follows: Antigen interacts with basophils or mast cells which express cell surface IgE, causing the release of platelet activating factors. These factors stimulate platelets to release vasoactive amines. These amines cause local endothelial cell retraction and deposition of greater than 198 immune complexes on the luminalaspect ofthe blood vessel wall.
As a result, the classic complement pathway is stimulated, and chemotactic factors are released. Neutrophils are attracted to the site, which release lysosomal enzymes that destroy the vascular wall, causing fibrinoid necrosis.
There is a group ofvasculitides which occurs both in animals and the human which are unexplained by this mechanism alone. Specifically, these lesions are characterized by lymphocyte and macrophage perivascular cuffs, which initiate vascular wall destruction by infiltrating the vascular adventitia and secondly the outer aspects of the tunica media. In more severe lesions, this process becomes totally transmural. Very little, if any, neutrophilic participation is observed (Fig. 2) .
In the MRL mice, mononuclear-cell vasculitis occurs as early as 12 weeks of age and clearly precedes the development of immune complex-mediated vasculitis. The inflammatory infiltrate is composed predominantly by Thy 1+, Ly 1+, L3T4-cells. A minority population ofMAC-l +, Ly 2+, asGM 1+ cells are also present (17) . These findings suggest that the initiation ofautoimmune vasculitis in MRLI lpr mice may be due to lymphocyte and macrophage-mediated injury to VSMCs. To address the question ofwhether cell-mediated immunologic mechanisms were involved in the expression of mononuclear-cell vasculitis, we chose to focus on whether VSMCs had an active or passive role in the influx of mononuclear inflammatory cells observed in vivo. Our approach was 1) to develop an in vitro VSMC model system, and 2) to inves- tigate whether lymphocytes and macrophages destroyed VSMCs through the use of co-cultivation studies.
DEVELOPMENT OF AN IN VITRO VSMC MODEL Dissection of the various components ofautoimmune mononuclear-cell vasculitis suggested that lymphocytes were the predominant initiators and mediators of VSMC injury. To investigate this hypothesis, an in vitro vascular smooth muscle cell model system was developed (16) . Mesenteric and aortic VSMCs from MRLllpr and C3H/Hej (C3H) normal control mice were grown in culture according to methods and criteria described by Gimbrone (9) and Charnley-Campbell (3). These blood vessels were chosen because they were known to be predilection sites for the development of vasculitis in MRL mice (17) . In vitro, VSMCs grew slowly, in a criss-cross pattern, and tended to layer themselves, forming a "hill and valley" effect. Functional integrity of cultured cells was confirmed by applying 1 x 10-6 angiotensin II to relaxed primary and subcultured cells, according to methods described by Ives et al (14) . We observed evaginations considered to be indicative of cellular contractions by 75% of the cellular population within 6 min. These findings concurred with those obtained by Ives.
The next step was to test the hypothesis: That lymphocytes from autoimmune animals initiated vascular smooth muscle cell injury in vitro. Our next step was to evaluate splenocyte and VSMC interactions in vitro. The next step was to determine whether lymphocytes from autoimmune, but not normal, mice initiated VSMC injury. We took advantage of the fact that we were able to derive VSMCs from MRL/lpr mice with fulminant clinical vasculitis and to compare them to VSMCs from age-matched C3H mice (20 weeks of age) which are H-2 histocompatible (H-2k), but do not spontaneously develop vasculitis. Splenocytes (l x 10 6 ) from MRL or C3H mice were co-cultivated with monolayer VSMCs derived from either MRL or C3H mice.
The results showed that between 2-4 hr, both MRL/lpr and C3H splenocytes adhered to and migrated over MRL/lpr VSMCs in a random pattern (Fig. 3) . Between 6-12 hr, however, splenocytes from both MRL/1pr and C3H mice progressively clustered around selected MRL/lpr VSMCs resulting in total envelopment of their surfaces (Fig. 4) and released selected VSMCs from the culture plate (16) .
Our original premise was that lymphocytes initiated VSMC destruction. However, based on these data, our attention shifted to the function of the VSMC itself. To determine whether or not C3H VSMCs initiated similar autoimmune and normal splenocyte adherence and envelopment [to C3H (normal) VSMCs], we repeated the co-cultivation studies with C3H VSMCs. The data indicated that C3H VSMCs did not induce splenocytes from either autoimmune (MRL/lpr) or normal (C3H) mice to be attracted to VSMCs during any time period. These findings indicated that the MRL/lpr VSMCs induced a splenocyte response which differed markedly from the response by the same populations of splenocytes to C3H VSMCs.
Close examination of the inflammatory cell morphology confirmed that a 5-7 JL, smooth to heavily microvillar, ovoid cell was the primary interacting cell with the VSMCs (Fig. 5) . These criteria are consistent with lymphocyte morphology. Scanning electron microscopy does not permit distinction between T-and B-Iymphocytes.
Therefore, the experiments, at this point, suggested a significant influx of'lymphocytes, regardless of origin, occurring in the presence of MRL/lpr VSMCs.
Our attention then turned to the possibility that MRL/lpr VSMCs were active participants in inducing the mononuclear-cell response. Studies were carried out to determine whether MRL/lpr VSMCs: I) released a factor which stimulated T-cells to proliferate, and 2) expressed the Class II MHC molecule,Ia. proliferation assay (19) . The results show that marked thymocyte proliferation occurred, due to the presence ofMRL/1pr, but not C3H, VSMC supernatants, except in primary culture, which probably reflectsa heterogeneous population ofcells (16) . Since these experiments were performed, Libby's laboratory has corroborated that VSMCs from human aortas release interleukin-1 after stimulation by exogenous agents such as endotoxin (23) .
EXPERIMENTS TO INVESTIGATE VSMC FUNCTION IN MONONUCLEAR-CELL VASCULITIS

Evaluation oj fa Expression by VSMCs
We next examined the spontaneous expression of Ia by fluorescence microscopy. Ia is a surface antigen coded for by the Class II major histocompatability (MHC) locus. The presence of this antigen on the surface of cells has defined a population of cells as accessory cells in the induction of T-cell function. MRL/1pr and C3H mice are syngeneic at the H-2 histocompatability locus and therefore, should they spontaneously express Ia, they would express Ia-k.
Two methods of indirect immunofluorescence were utilized to evaluate VSMC Ia expression-fluorescence microscopy and flow cytometry.
Fluorescence microscopy showed that MRL/1pr VSMCs spontaneously expressed Ia-k in a granular cytoplasmic pattern (16) . Indirect immunofluorescence staining using IgG2a as a control produced minimal non-specific perinuclear immunofluorescence. C3H VSMCs, in contrast, did not exhibit positive staining for Ia.
Since quantification offluorescence intensity, and thereby degree of antigen expression, is not reliable by fluorescence microscopy alone, we attempted to quantify Ia expression by flow cytometry. Flow cytometry requires single cell suspensions of uniformly spherical cells. In our hands, analysis of single VSMC suspensions created technical problems which resulted in erroneous data.
We solved these problems by culturing VSMCs on microspheres (5), a technique which allowed flow cytometric analysis without placing the cells into suspension.
We then turned to analyzing VSMCs cultured on microspheres for the expression ofIa-k and Ia-d by flow cytometry (Ortho Spectrum III). We examined the VSMCs for the second type of Class II MHC molecule, since the expression of this cell surface antigen could be a mechanism ofVSMC recognition and subsequent destruction by lymphocytes. The first set ofexperiments confirmed that C3H VSMCs exhibited normal background fluorescence only, and did not spontaneously express the Ia-k antigen. In contrast, a few MRL VSMCs express background fluorescence, but the majority of cells expressed the Ia-k antigen-confirming our earlier observations made by fluorescence microscopy (16) .
We then turned to evaluating whether MRL/1pr VSMCs may also express Ia-d, an antigen which should not be expressed in the normal state. These experiments showed that C3H VSMCs express only background fluorescence (Fig. 6 ), but MRL/1pr VSMCs, on the other hand, express Ia-d (Fig. 7) . These findings indicate that MRL/ 1pr, but not C3H, VSMCs express Ia-k and Ia-d and they do so spontaneously.
Since cells, which express Ia and release Il-1, may function as accessory cells to stimulate T-celllymphocyte function. The next step was to determine whether MRL/1pr VSMCs might function in this manner and thereby present soluble antigen. To test antigen presentation, graded dilutions of VSMCs were co-cultivated with syngeneic C3H T-cells, primed to soluble antigen, which in this case was ovalbumin, according to standard techniques (12, 20) . By 24 hr of culture, T-cells attached to MRL/ lpr VSMCs in the presence of ovalbumin. In contrast, T-cells were usually randomly distributed over C3H VSMCs, although occasional small clusters were noted. Activation ofprimed T-cells by the presentation of ovalbumin by VSMCs was quantified by measuring uptake of 3H-thymidine by T-cells 48 hr post co-cultivation. As shown in Table I , T-cells cultured with ovalbumin and MRL/1pr VSMCs increased incorporation of3H-thymidine by T-cells to 5,600, 10,000, and 16,693 cpm, respectively. Further, the T-cell response was directly dose-dependent to the VSMC dilution. C3H VSMCs mildly stimulated T-cell proliferation up to 4,100 cpm. These experiments suggestedthat VSMCs may func- tion as accessory cells to T-cell function in a Class II MHC-restricted fashion. However, macrophage contamination in these cultures was still a consideration. To address this possibility, our next step was to evaluate the ability of VSMCs to stimulate T-cell clones and hybrids raised against specific antigens to proliferate in the presence, but not the absence, ofthese antigens. To date, in collaboration with Dr. Dave Parker (University of Massachusetts Medical Center), we have not observed proliferation of any of the T-cell hybrids tested, suggesting that under these precise experimental conditions, VSMCs from neither MRL/I pr mice with autoimmune vasculitis nor age-matched MRL/+/+ mice without vasculitis present antigen to these T -cell lines, raising, among many, questions of whether or not VSMCs function as primary accessory cells or whether they function in conjunction with macrophages to enhance T-cell proliferation (similar to dendritic cells). These results raise several questions concerning the function ofMRL/1pr VSMCs in support ofT-cell proliferation. Future experiments include the determination of whether or not VSMCs alternatively stimulate T-cell proliferation in an autologous mixed lymphocyte response, a second mechanism by which VSMCs may stimulate T-cell function in a Class II MHC-restricted fashion. Secondly, we are attempting to grow site-specific inflammatory cells directly from the lesion site to determine their contribution to the expression of VSMC function in this lesion.
As a result ofthese studies, ourcurrent hypothesis (Fig. 8) : Lymphocytes congregate at the perivascular site. Vascular smooth muscle cells stimulate lymphocytes to proliferate and to preferentially migrate to the VSMC surface. The lymphocytes bind to the VSMC, causing greater numbers of lymphocytes to be attracted to the site. Macrophages are also present and may functionally amplify the lesion by releasing enzymes which break down connective tissue and permit improved lymphocyte infiltration and/or collaborate with VSMCs to modulate T -lymphocyte function. As a result, VSMCs are destroyed, possibly as a result of their aberrant Ia-d expression.
